Novavax COVID-19 vaccine could be approved very soon, says EMA chief

The head of the European Medicines Agency (EMA) on Tuesday said that it could soon approve the COVID-19 vaccine developed by U.S. biotech company Novavax (NVAX.O). 'The vaccine from Novavax could be authorised in the very near future,' Emma Cooke told EU health ministers during a public session of a meeting in Brussels.